|
1
|
Natarajan J, Chandrashekar C and
Radhakrishnan R: Critical biomarkers of epithelial-mesenchymal
transition in the head and neck cancers. J Cancer Res Ther.
10:512–518. 2014.PubMed/NCBI
|
|
2
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li ZH and Bresnick AR: The S100A4
metastasis factor regulates cellular motility via a direct
interaction with myosin-IIA. Cancer Res. 66:5173–5180. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sarrió D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scanlan MJ, Raj BK, Calvo B, Garin-Chesa
P, Sanz-Moncasi MP, Healey JH, Old LJ and Rettig WJ: Molecular
cloning of fibroblast activation protein alpha, a member of the
serine protease family selectively expressed in stromal fibroblasts
of epithelial cancers. Proc Natl Acad Sci USA. 91:5657–5661. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huber MA, Kraut N, Park JE, Schubert RD,
Rettig WJ, Peter RU and Garin-Chesa P: Fibroblast activation
protein: Differential expression and serine protease activity in
reactive stromal fibroblasts of melanocytic skin tumors. J Invest
Dermatol. 120:182–188. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kraman M, Bambrough PJ, Arnold JN, Roberts
EW, Magiera L, Jones JO, Gopinathan A, Tuveson DA and Fearon DT:
Suppression of antitumor immunity by stromal cells expressing
fibroblast activation protein-alpha. Science. 330:827–830. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aertgeerts K, Levin I, Shi L, Snell GP,
Jennings A, Prasad GS, Zhang Y, Kraus ML, Salakian S, Sridhar V, et
al: Structural and kinetic analysis of the substrate specificity of
human fibroblast activation protein alpha. J Biol Chem.
280:19441–19444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Levy MT, McCaughan GW, Abbott CA, Park JE,
Cunningham AM, Müller E, Rettig WJ and Gorrell MD: Fibroblast
activation protein: A cell surface dipeptidyl peptidase and
gelatinase expressed by stellate cells at the tissue remodelling
interface in human cirrhosis. Hepatology. 29:1768–1778. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Christiansen VJ, Jackson KW, Lee KN and
McKee PA: Effect of fibroblast activation protein and
alpha2-antiplasmin cleaving enzyme on collagen types I, III and IV.
Arch Biochem Biophys. 457:177–186. 2007. View Article : Google Scholar
|
|
11
|
Aggarwal S, Brennen WN, Kole TP, Schneider
E, Topaloglu O, Yates M, Cotter RJ and Denmeade SR: Fibroblast
activation protein peptide substrates identified from human
collagen I derived gelatin cleavage sites. Biochemistry.
47:1076–1086. 2008. View Article : Google Scholar
|
|
12
|
O'Brien P and O'Connor BF: Seprase: An
overview of an important matrix serine protease. Biochim Biophys
Acta. 1784:1130–1145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lai D, Ma L and Wang F: Fibroblast
activation protein regulates tumor-associated fibroblasts and
epithelial ovarian cancer cells. Int J Oncol. 41:541–550. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wikberg ML, Edin S, Lundberg IV, Van
Guelpen B, Dahlin AM, Rutegård J, Stenling R, Oberg A and Palmqvist
R: High intratumoral expression of fibroblast activation protein
(FAP) in colon cancer is associated with poorer patient prognosis.
Tumour Biol. 34:1013–1020. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saigusa S, Toiyama Y, Tanaka K, Yokoe T,
Okugawa Y, Fujikawa H, Matsusita K, Kawamura M, Inoue Y, Miki C, et
al: Cancer-associated fibroblasts correlate with poor prognosis in
rectal cancer after chemoradiotherapy. Int J Oncol. 38:655–663.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cohen SJ, Alpaugh RK, Palazzo I, Meropol
NJ, Rogatko A, Xu Z, Hoffman JP, Weiner LM and Cheng JD: Fibroblast
activation protein and its relationship to clinical outcome in
pancreatic adenocarcinoma. Pancreas. 37:154–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia J, Martin TA, Ye L and Jiang WG: FAP-α
(Fibroblast activation protein-α) is involved in the control of
human breast cancer cell line growth and motility via the FAK
pathway. BMC Cell Biol. 15:162014. View Article : Google Scholar
|
|
18
|
Okada K, Chen WT, Iwasa S, Jin X, Yamane
T, Ooi A and Mitsumata M: Seprase, a membrane-type serine protease,
has different expression patterns in intestinal- and diffuse-type
gastric cancer. Oncology. 65:363–370. 2003. View Article : Google Scholar
|
|
19
|
Kashyap MK, Marimuthu A, Kishore CJ, Peri
S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P,
Sanjeeviah RC, et al: Genomewide mRNA profiling of esophageal
squamous cell carcinoma for identification of cancer biomarkers.
Cancer Biol Ther. 8:36–46. 2009. View Article : Google Scholar
|
|
20
|
Zhang MZ, Qiao YH, Nesland JM, Trope C,
Kennedy A, Chen WT and Suo ZH: Expression of seprase in effusions
from patients with epithelial ovarian carcinoma. Chin Med J (Engl).
120:663–668. 2007.
|
|
21
|
Iwasa S, Okada K, Chen WT, Jin X, Yamane
T, Ooi A and Mitsumata M: 'Increased expression of seprase, a
membrane-type serine protease, is associated with lymph node
metastasis in human colorectal cancer'. Cancer Lett. 227:229–236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang XM, Yu DM, McCaughan GW and Gorrell
MD: Fibroblast activation protein increases apoptosis, cell
adhesion, and migration by the LX-2 human stellate cell line.
Hepatology. 42:935–945. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Y, Simms AE, Mazur A, Wang S, León
NR, Jones B, Aziz N and Kelly T: Fibroblast activation protein-α
promotes tumor growth and invasion of breast cancer cells through
non-enzymatic functions. Clin Exp Metastasis. 28:567–579. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y,
Zhang Y, Hua S, Fu Q, Zhao M, et al: Downregulation of FAP
suppresses cell proliferation and metastasis through PTEN/PI3K/AKT
and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death
Dis. 5:e11552014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lv B, Xie F, Zhao P, Ma X, Jiang WG, Yu J,
Zhang X and Jia J: Promotion of cellular growth and motility is
independent of enzymatic activity of fibroblast activation
protein-α. Cancer Genomics Proteomics. 13:201–208. 2016.PubMed/NCBI
|
|
26
|
Goodman JD, Rozypal TL and Kelly T:
Seprase, a membrane-bound protease, alleviates the serum growth
requirement of human breast cancer cells. Clin Exp Metastasis.
20:459–470. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng JD, Dunbrack RL Jr, Valianou M,
Rogatko A, Alpaugh RK and Weiner LM: Promotion of tumor growth by
murine fibroblast activation protein, a serine protease, in an
animal model. Cancer Res. 62:4767–4772. 2002.PubMed/NCBI
|
|
28
|
Huang Y, Wang S and Kelly T: Seprase
promotes rapid tumor growth and increased microvessel density in a
mouse model of human breast cancer. Cancer Res. 64:2712–2716. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang L, Ma L and Lai D: Over-expression of
fibroblast activation protein alpha increases tumor growth in
xenografts of ovarian cancer cells. Acta Biochim Biophys Sin
(Shanghai). 45:928–937. 2013. View Article : Google Scholar
|
|
30
|
Du H, Chen D, Zhou Y, Han Z and Che G:
Fibroblast phenotypes in different lung diseases. J Cardiothorac
Surg. 9:1472014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang W, Han W, Ye S, Liu D, Wu J, Liu H,
Li C and Chen H: Fibroblast activation protein-α promotes ovarian
cancer cell proliferation and invasion via extracellular and
intracellular signaling mechanisms. Exp Mol Pathol. 95:105–110.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chung KM, Hsu SC, Chu YR, Lin MY, Jiaang
WT, Chen RH and Chen X: Fibroblast activation protein (FAP) is
essential for the migration of bone marrow mesenchymal stem cells
through RhoA activation. PLoS One. 9:e887722014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zi FM, He JS, Li Y, Wu C, Wu WJ, Yang Y,
Wang LJ, He DH, Yang L, Zhao Y, et al: Fibroblast activation
protein protects bortezomib-induced apoptosis in multiple myeloma
cells through β-catenin signaling pathway. Cancer Biol Ther.
15:1413–1422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Henriksson ML, Edin S, Dahlin AM,
Oldenborg PA, Åberg Ö, Van Guelpen B, Rutegård J, Stenling R and
Palmqvist R: Colorectal cancer cells activate adjacent fibroblasts
resulting in FGF1/FGFR3 signaling and increased invasion. Am J
Pathol. 178:1387–1394. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Katsuno Y, Lamouille S and Derynck R:
TGF-β signaling and epithelial-mesenchymal transition in cancer
progression. Curr Opin Oncol. 25:76–84. 2013. View Article : Google Scholar
|
|
36
|
Sánchez-Tilló E, Liu Y, de Barrios O,
Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A
and Postigo A: EMT-activating transcription factors in cancer:
Beyond EMT and tumor invasiveness. Cell Mol Life Sci. 69:3429–3456.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yue D, Li H, Che J, Zhang Y, Tseng HH, Jin
JQ, Luh TM, Giroux-Leprieur E, Mo M, Zheng Q, et al: Hedgehog/Gli
promotes epithelial-mesenchymal transition in lung squamous cell
carcinomas. J Exp Clin Cancer Res. 33:342014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu X, Su B, Xie C, Wei S, Zhou Y, Liu H,
Dai W, Cheng P, Wang F, Xu X, et al: Sonic hedgehog-Gli1 signaling
pathway regulates the epithelial mesenchymal transition (EMT) by
mediating a new target gene, S100A4, in pancreatic cancer cells.
PLoS One. 9:e964412014. View Article : Google Scholar : PubMed/NCBI
|
